L18I

Kundenbewertung

Based on 1 Customer Validation

L18I is a PROTAC targeting Btk that can reduce inflammation in autoimmune diseases such as lupus erythematosus induced by BM12 splenocytes. The active control of the target protein ligand of L18I is IBT6A-CO-ethyne (HY-163963), and the conjugate of E3 ubiquitin ligase ligand + Linker of L18I is Lenalidomide-C3-PEG3-N3 (HY-163964)[1].
(Pink: Btk ligand (HY-13036A); Blue: Cereblon ligand (HY-43722); Black: linker (HY-41921)).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.43%
  • CAS. Nr.: 2451070-32-7
  • Formel: C47H51N11O8
  • Molecular Weight:897.98
  • Speicherung:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Lösungsmittel & Löslichkeit
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle PROTACs Isoform-spezifische Produkte anzeigen

More
100 mg

Angebot einholen Auf Lager

Please select quantity
Amount: USD 0.00